Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    Study of the effect of a probiotic on autonomic and psychological stress
Previous Study | Return to List | Next Study

Study on the Effects of a Probiotic on Autonomic and Psychological Stress

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02417454
Recruitment Status : Completed
First Posted : April 15, 2015
Last Update Posted : October 19, 2017
Sponsor:
Collaborator:
Lallemand Health Solutions
Information provided by (Responsible Party):
McMaster University

Brief Summary:
The purpose of this study is to investigate the effects of a probiotic blend on qualitative (subjective interviews and self-reporting) and quantitative (changes in brain activity, heart rate, cortisol, and reactivity) measures of stress in healthy undergraduate students.

Condition or disease Intervention/treatment Phase
Stress, Psychological Dietary Supplement: ProbioStick Other: Placebo Phase 3

Detailed Description:

There is a burgeoning literature involving nonhuman animal and human studies linking the microbiota environment in the gut to brain-behaviour relations. For example, animal studies demonstrate that germ-free rodents show heightened HPA-axis responses to stress compared to gnotobiotic animals. There are also a number of nonhuman and human studies that show positive effects of reducing stress after being treated with different probiotics. For example, in one recent double blind study in humans using standardized questionnaires indicated a greater reduction of stress and anxiety symptoms after one month of supplementation with a probiotic formulation compared to placebo. The groups were also differentiated by urinary cortisol levels after treatment. Other studies have found positive effects of probiotic treatment and stress reduction using other probiotics. Accordingly, there is accumulating empirical evidence from animal and human studies of the positive effects of probiotic treatment on stress reduction.

In this study, the investigators will investigate the stress reduction effects of the Lallemand Health Solutions (LHS) Probio'Stick® on healthy undergraduate students. The study will be conducted at the McMaster LIVELab, which is capable of collecting both physiological and behavioural measures from groups of up to 100 participants at a time.

Registration into this clinical trial will require students be screened via McMaster's SONA system (mcmaster.sona-systems.com). After the screening, participants that are eligible to participate will be given the option to register for an information meeting at which point one may opt to enrol in the study or not.

Once in the study, participants will undergo an initial screening in the LIVELab where they will be exposed to auditory, visual, and performance based stressors to measure a baseline. After such point, they will be randomized to receive Probio'Stick® or placebo for a 6-week, once daily, probiotic treatment at home. Following the 6 week intervention, participants will return to the lab for a second testing using the same procedures to establish a change from baseline.


Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 128 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: A Double Blind Placebo Controlled Study on the Effects of a Probiotic on Autonomic and Psychological Stress Responses in Volunteers
Study Start Date : September 2015
Actual Primary Completion Date : August 2017
Actual Study Completion Date : August 2017

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Stress

Arm Intervention/treatment
Experimental: Probiotic
Participants will undergo the same study procedures as for the comparator; however, the product given will be the active probiotic supplement (ProbioStick).
Dietary Supplement: ProbioStick

One sachet daily, without or without meals (3 x 10^9 CFU per sachet)

(Lactobacillus helveticus R0052 and Bifidobacterium longum subsp. longum R0175)


Placebo Comparator: Placebo
Participants will undergo the same study procedures as for the probiotic; however, the product given will be a placebo, identical to the probiotic in taste, smell, colour, and comprised only of the same non-active ingredients in the probiotic supplement
Other: Placebo
One sachet daily, without or without meals (0 CFU per sachet)




Primary Outcome Measures :
  1. Changes in right frontal electroencephalography (EEG)/brain activity [ Time Frame: Visit 1 and Visit 2 (6 weeks apart) ]
    Is a measure of stress/arousal

  2. Changes in salivary cortisol concentrations [ Time Frame: Pre and Post Visit 1 and Visit 2 (6 weeks apart) ]
    Collected via Salivette®, before and after each session in the lab.

  3. Change in the magnitude of startle response [ Time Frame: Visit 1 and Visit 2 (6 weeks apart) ]
    Measured as facial electromyography (EMG) change

  4. Changes in sympathetic nervous system activation [ Time Frame: Visit 1 and Visit 2 (6 weeks apart) ]
    Calculated as a measure of Heart Rate Variability (HRV) from electrocardiography (ECG) data


Secondary Outcome Measures :
  1. Changes in Anxiety Scores as determined by the Beck Anxiety Inventory (BAI) [ Time Frame: Visit 1 and Visit 2 (6 weeks apart) ]
  2. Changes in Stress Scores as determined by Cohen's Perceived Stress Scale (PSS) [ Time Frame: Visit 1 and Visit 2 (6 weeks apart) ]
  3. Changes in General Affect Scores as determined by the Positive and Negative Affect Scale (PANAS) [ Time Frame: Visit 1 and Visit 2 (6 weeks apart) ]
  4. Changes in Stress Scores as reported on a 1-10 Likert Scale [ Time Frame: Visit 1 and Visit 2 (6 weeks apart) ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Answering "Yes" to questions 3, 8 and 9 of the Cohen's Perceived Stress Scale.
  • Willingness to complete questionnaires, records, and diaries associated with the study and to complete all site visits.
  • Willingness to discontinue consumption of fermented foods or probiotics (e.g. yogurts, with live, active cultures, or supplements).
  • Ability to provide informed consent.

Exclusion Criteria:

  • Must not be currently taking another probiotic regiment or another investigational product within 3 months of the screening visit.
  • Must not currently be taking medications for depression or anxiety, including benzodiazepines, SSRIs, or antipsychotics or receiving counselling for depression or anxiety.
  • Must not be immune-compromised or immuno-suppressed (e.g. AIDS, lymphoma, participants undergoing long-term corticosteroid treatment, chemotherapy and allograft participants).
  • Must not have experienced bloody diarrhea in the past month prior to beginning the study.
  • Must not have undergone any surgery within the three months prior to beginning the study, particularly surgeries involving the colon.
  • Must not have any soy or milk allergy.
  • Must not be pregnant or breast-feeding or planning on becoming pregnant.
  • Must not have used of any antibiotic drug (e.g., neomycin, rifaximin) within 1 month of screening.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02417454


Locations
Layout table for location information
Canada, Ontario
McMaster LIVELab
Hamilton, Ontario, Canada, L8S 4L8
Sponsors and Collaborators
McMaster University
Lallemand Health Solutions
Investigators
Layout table for investigator information
Principal Investigator: Laurel Trainor, Ph.D. McMaster University

Additional Information:
Publications:
Lang PJ, Bradley MM, Cuthbert BN. International affective picture system (IAPS): Affective ratings of pictures and instruction manual.. Technical Report A-8. University of Florida, Gainesville, FL.; 1995.
Gasser F. Safety of lactic acid bacteria and their occurrence in human clinical infections. Bull Inst Past. 1994;92:45-67.
European Food Safety Authority. Guidance on the assessment of bacterial susceptibility to antimicrobials of human and veterinary importance. EFSA Journal. 2012;10(6).

Layout table for additonal information
Responsible Party: McMaster University
ClinicalTrials.gov Identifier: NCT02417454     History of Changes
Other Study ID Numbers: 20000229
First Posted: April 15, 2015    Key Record Dates
Last Update Posted: October 19, 2017
Last Verified: October 2017

Keywords provided by McMaster University:
probiotic
stress
emotion psychophysiology
brain-body-gut interactions

Additional relevant MeSH terms:
Layout table for MeSH terms
Stress, Psychological
Behavioral Symptoms